Pharmaust Limited

ASX:PAA ISIN:AU000000PAA1

PharmAust LtdPharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust's other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.

 
    
          

查看其它語言版本

新聞

2011年2月10日澳洲股市:Calzada (ASX:CZD)宣佈人類骨骼生長干細胞研究取得積極結果

🕔2/10/2011 1:30:00 PM 11433

2011年2月10日澳洲股市報告包括:Calzada (ASX:CZD)宣佈人類骨骼生長干細胞研究取得積極結果;PharmAust Limited (ASX:PAA)將收購歐洲高品位貴金屬和基礎金屬項目;Northern Star Resources (ASX:NST)宣布西澳黃金生產強勁結果;Latin Resources Limited (ASX:LRS)將收購秘魯14,068公頃的世界級鐵及重礦砂礦權地。

閱讀全文

ABN Newswire股票看點:2010年3月24日

🕔3/24/2010 11:00:05 AM 15207

ABN Newswire今天的股票看點包括:iSOFT Group Limited (ASX:ISF)、AuDAX Resources Limited (ASX:ADX) (PINK:ADXRF)、Clean Global Energy Limited (ASX:CGV)和Brickworks Limited (ASX:BKW)。

閱讀全文
###

127,669 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 14) (過去30日: 84) (自發布以來: 11667) 

公司詳細

    總部
  • Suite 39, 1 Freshwater Parade
    Claremont WA 6010
    Australia
  • 電話
  • +61 (8) 9202 6814 
  • 傳真
  • +61 8 9467 6111 
  • 主要部門
  • 醫療-製藥 
  • 支柱產業
  • 生物科技 
  • 主頁
  • www.pharmaust.com
  • E:
  • rogeraston@pharmaust.com

更多新聞紀錄

  • 2024/10/09: Results of Annual General Meeting*
  • 2024/10/09: AGM Presentation*
  • 2024/10/09: Chairman's AGM Address*
  • 2024/10/09: PharmAust Receives R&D Tax Incentive Rebate*
  • 2024/09/30: Section 708A Cleansing Statement*
  • 2024/09/30: Application for quotation of securities - PAA*
  • 2024/09/17: EMA pre-submission meeting paves the way for OMPD Request*
  • 2024/09/05: Proposed issue of securities - PAA*
  • 2024/09/05: Notice of Annual General Meeting/Proxy Form*
  • 2024/09/02: Section 708A Cleansing Statement*
*refer to company website

社會化媒體